Adverse events42

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 42

Type	Event	Organ system	Group	Affected	At risk
other	Diarrhoea	Gastrointestinal disorders	Safety Population: Placebo	2	44
other	Diarrhoea	Gastrointestinal disorders	Safety Population: Teprotumumab	5	43
other	Nausea	Gastrointestinal disorders	Safety Population: Placebo	4	44
other	Nausea	Gastrointestinal disorders	Safety Population: Teprotumumab	8	43
other	Fatigue	General disorders	Safety Population: Placebo	6	44
other	Fatigue	General disorders	Safety Population: Teprotumumab	3	43
other	Upper respiratory tract infection	Infections and infestations	Safety Population: Placebo	4	44
other	Upper respiratory tract infection	Infections and infestations	Safety Population: Teprotumumab	0	43
other	Weight decreased	Investigations	Safety Population: Placebo	0	44
other	Weight decreased	Investigations	Safety Population: Teprotumumab	3	43
other	Hyperglycaemia	Metabolism and nutrition disorders	Safety Population: Placebo	2	44
other	Hyperglycaemia	Metabolism and nutrition disorders	Safety Population: Teprotumumab	5	43
other	Muscle spasms	Musculoskeletal and connective tissue disorders	Safety Population: Placebo	2	44
other	Muscle spasms	Musculoskeletal and connective tissue disorders	Safety Population: Teprotumumab	8	43
other	Dizziness	Nervous system disorders	Safety Population: Placebo	4	44
other	Dizziness	Nervous system disorders	Safety Population: Teprotumumab	0	43
other	Dysgeusia	Nervous system disorders	Safety Population: Placebo	0	44
other	Dysgeusia	Nervous system disorders	Safety Population: Teprotumumab	3	43
other	Headache	Nervous system disorders	Safety Population: Placebo	2	44
other	Headache	Nervous system disorders	Safety Population: Teprotumumab	3	43

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01868997/events

API reference For AI assistants

Adverse events42

Sources 3

Read this list from software.